Emergent BioSolutions (EBS) Tops Q2 EPS by $1.30, Raises Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.25 -0.19 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.44 | 52 Week High | $44.38 | |||
| Open | $5.51 | 52 Week Low | $24.47 | |||
| Day High | $7.22 | P/E | 312.50 | |||
| Day Low | $5.51 | EPS | $0.02 | |||
| Volume | 3,067,191 | |||||
